- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Financially Fit Penny Stocks
Swedish Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
38
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
38 companies
Biovica International
Market Cap: SEK 68.5m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.
BIOVIC B
SEK 0.70
7D
-18.6%
1Y
-69.6%
Newbury Pharmaceuticals
Market Cap: SEK 81.3m
Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.
NEWBRY
SEK 3.35
7D
0%
1Y
-2.0%
Elicera Therapeutics
Market Cap: SEK 148.5m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 3.06
7D
4.8%
1Y
150.8%
NextCell Pharma
Market Cap: SEK 78.2m
A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.
NXTCL
SEK 1.07
7D
-62.2%
1Y
-62.5%
Ascelia Pharma
Market Cap: SEK 263.3m
A biotech company, focuses on orphan oncology treatments in Sweden.
ACE
SEK 2.74
7D
7.5%
1Y
-76.2%
AcouSort
Market Cap: SEK 56.0m
A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.
ACOU
SEK 3.75
7D
-2.8%
1Y
-68.4%
Lipigon Pharmaceuticals
Market Cap: SEK 18.4m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.12
7D
-1.9%
1Y
-59.3%
Modus Therapeutics Holding
Market Cap: SEK 44.4m
A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.
MODTX
SEK 1.24
7D
6.5%
1Y
18.8%
AlzeCure Pharma
Market Cap: SEK 215.4m
A pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 2.44
7D
-6.5%
1Y
19.0%
Nanologica
Market Cap: SEK 73.5m
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide.
NICA
SEK 0.83
7D
-15.4%
1Y
-85.4%
SenzaGen
Market Cap: SEK 128.9m
Provides non-animal tests for assessing a substance’s allergenicity.
SENZA
SEK 4.37
7D
-1.6%
1Y
-45.4%
Alzinova
Market Cap: SEK 166.4m
A biopharmaceutical company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 1.87
7D
-1.1%
1Y
-0.7%
Annexin Pharmaceuticals
Market Cap: SEK 145.0m
A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.
ANNX
SEK 0.27
7D
-10.5%
1Y
-1.1%
AroCell
Market Cap: SEK 129.0m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
AROC
SEK 0.56
7D
14.5%
1Y
60.5%
Enorama Pharma
Market Cap: SEK 134.3m
A pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden.
ERMA
SEK 2.22
7D
13.8%
1Y
-35.5%
Intervacc
Market Cap: SEK 320.0m
Develops novel veterinary vaccines for animals in Sweden.
IVACC
SEK 0.94
7D
-2.6%
1Y
-77.0%
Stayble Therapeutics
Market Cap: SEK 26.3m
Develops injectable treatment for chronic pain triggered by disc degeneration.
STABL
SEK 0.51
7D
13.6%
1Y
115.7%
Genetic Analysis
Market Cap: NOK 32.8m
A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.
GEAN
NOK 0.67
7D
-6.3%
1Y
-52.8%
Toleranzia
Market Cap: SEK 109.2m
A biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases.
TOL
SEK 0.40
7D
-2.9%
1Y
-17.1%
Enzymatica
Market Cap: SEK 825.3m
A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.
ENZY
SEK 3.40
7D
-4.5%
1Y
-10.5%
Level Bio
Market Cap: SEK 26.7m
Designs, develops, and distributes diagnostics products in the Nordic region and internationally.
LEVBIO
SEK 0.39
7D
13.0%
1Y
30.0%
Vivesto
Market Cap: SEK 127.5m
Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 0.24
7D
-0.8%
1Y
-22.9%
Inhalation Sciences Sweden
Market Cap: SEK 65.8m
Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.
ISAB
SEK 4.34
7D
0%
1Y
24.4%
Aptahem
Market Cap: SEK 20.0m
A biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.
APTA
SEK 1.60
7D
13.9%
1Y
-49.7%
Spago Nanomedical
Market Cap: SEK 69.6m
A clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden.
SPAGO
SEK 0.20
7D
4.7%
1Y
-31.0%
Egetis Therapeutics
Market Cap: SEK 1.4b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 3.77
7D
-6.3%
1Y
-38.0%
Mendus
Market Cap: SEK 241.7m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 4.80
7D
-15.7%
1Y
-53.6%
PExA
Market Cap: SEK 9.8m
Develops and commercializes diagnostic products in various respiratory diseases, such as asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary diseases.
PEXA B
SEK 0.17
7D
-11.1%
1Y
-54.4%
CombiGene
Market Cap: SEK 47.1m
Engages in the development of gene therapy for severe life-altering diseases in Sweden.
COMBI
SEK 2.38
7D
1.3%
1Y
-39.9%
Dicot Pharma
Market Cap: SEK 482.9m
Engages in the development of pharmaceutical products in Sweden.
DICOT
SEK 0.27
7D
-3.0%
1Y
4.6%
Sprint Bioscience
Market Cap: SEK 44.8m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 0.64
7D
-7.2%
1Y
-49.0%
Attana
Market Cap: SEK 26.2m
Provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia.
ATANA
SEK 0.029
7D
314.3%
1Y
-59.2%
Medivir
Market Cap: SEK 140.2m
A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.
MVIR
SEK 1.25
7D
1.2%
1Y
-53.4%
LIDDS
Market Cap: SEK 4.6m
A drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden.
LIDDS
SEK 0.034
7D
-43.7%
1Y
-79.5%
Kancera
Market Cap: SEK 145.2m
Develops drugs for inflammatory diseases and cancer in Sweden and internationally.
KAN
SEK 1.20
7D
8.7%
1Y
-23.2%
Isofol Medical
Market Cap: SEK 287.5m
A clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally.
ISOFOL
SEK 1.78
7D
-9.1%
1Y
144.2%